Varonis System Inc (VRNS) Drops 7.08% on January 19

Equities Staff |

Varonis System Inc (VRNS) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 7.08% to $17.33, a loss of $-1.32 per share. Starting at an opening price of $18.90 a share, the stock traded between $17.18 and $19.51 over the course of the trading day. Volume was 116,253 shares over 1,280 trades, against an average daily volume of 158,881 shares and a total float of 25.76 million.

The losses send Varonis System Inc down to a market cap of $446.39 million. In the last year, Varonis System Inc has traded between $38.48 and $14.57, and its 50-day SMA is currently $17.30 and 200-day SMA is $20.25.

Varonis Systems Inc is engaged in providing software platform that allows enterprises to map, analyze, manage & utilize its unstructured data. It offers human-generated data including word processing documents, spreadsheets, & presentations.

Varonis System Inc is based out of New York, NY and has some 840 employees. Its CEO is Yakov Faitelson.

For a complete fundamental analysis analysis of Varonis System Inc, check out’s Stock Valuation Analysis report for VRNS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…